Magnus Nylén is a senior life science executive with more than 25 years of experience in building, scaling and commercializing pharmaceutical and healthcare businesses. He combines an entrepreneurial track record with extensive experience from international pharmaceutical companies and private equity-backed businesses, with particular expertise in turning strategy, and innovation into commercial growth.

Before joining ScandiBio Therapeutics, Magnus served as CEO of Bohus Biotech and Trimb Healthcare, and as Chief Commercial Officer at Karo Healthcare. He has also held senior leadership positions at Exeltis and Actavis. Throughout his career, he has led businesses and commercial organizations across the Nordics and wider European markets, with extensive experience from entrepreneurial, private equity-backed and international pharmaceutical environments.